Axolabs at TIDES Europe 2026
Nov 3–5, 2026 Amsterdam, Netherlands ~900 attendees Website
Axolabs takes part in 2 sessions at TIDES Europe 2026 in Amsterdam, and exhibits. Its sessions centre on the cost and speed of oligonucleotide development, from integrated strategies that move a nominated candidate to first-in-human to the CMC decisions that drive cost of goods in scale-up. The cost-of-goods discussion, run with Livinovea, weighs scientific and commercial levers.
| Organization | TIDES Europe 2026 Attendance |
|---|---|
Axolabs Kulmbach, Germany | |
Oligonucleotide contract research and manufacturing organization offering discovery, preclinical, analytical and GMP manufacturing services. | Booth Exhibiting (no floor booth listed) Wed, Nov 49:35am–4:15pmThu, Nov 59:35am–4:00pm Talk Tue Nov 3 09:00–12:00 CMC Decisions That Influence Cost of Goods (COGs) in Oligo Scale-up: Levers for Scientific and Commercial Impact Which early manufacturing and quality decisions set what an oligonucleotide drug costs to produce, and when in development they should be taken. Talk Wed Nov 4 13:25–13:55 From Development Candidate Nomination to First-in-Human: Accelerating Oligonucleotide Development Through Integrated Strategies What it took to move a sugar-tagged siRNA candidate from selection to its first human trial on a tight schedule. OligonucleotidesCMC & Manufacturing |
Instantly find 20 buyers from Axolabs
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or TIDES Europe. Submit a correction